🚀 VC round data is live in beta, check it out!
DaVita Valuation Multiples
Discover revenue and EBITDA valuation multiples for DaVita and similar public comparables like Bangkok Dusit Medical Services, Encompass Health, Max Healthcare Institute, Mayapada Hospital and more.
DaVita Overview
About DaVita
DaVita is the largest provider of dialysis services in the United States, boasting market share of about 35% when measured by clinics. The firm operates over 3,000 facilities worldwide, mostly in the US, and treats about 280,000 patients globally each year. Government payers dominate US dialysis reimbursement. DaVita receives about two thirds of US sales at government (primarily Medicare) reimbursement rates, with the remainder coming from commercial insurers. While commercial insurers represent only about 10% of US patients treated, they represent nearly all of the profits generated by DaVita in the US dialysis business.
Founded
1994
HQ
Employees
78.0K
Website
Sectors
Financials (LTM)
EV
$22B
DaVita Financials
DaVita reported last 12-month revenue of $14B and EBITDA of $3B.
In the same LTM period, DaVita generated $4B in gross profit, $3B in EBITDA, and $857M in net income.
Revenue (LTM)
DaVita P&L
In the most recent fiscal year, DaVita reported revenue of $14B and EBITDA of $3B.
DaVita expects next 12-month revenue of XXX and NTM EBITDA of XXX
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Revenue | $14B | XXX | $14B | XXX | XXX | XXX |
| Gross Profit | $4B | XXX | $4B | XXX | XXX | XXX |
| Gross Margin | 32% | XXX | 32% | XXX | XXX | XXX |
| EBITDA | $3B | XXX | $3B | XXX | XXX | XXX |
| EBITDA Margin | 21% | XXX | 21% | XXX | XXX | XXX |
| EBIT Margin | 15% | XXX | 15% | XXX | XXX | XXX |
| Net Profit | $857M | XXX | $818M | XXX | XXX | XXX |
| Net Margin | 6% | XXX | 6% | XXX | XXX | XXX |
| Net Debt | — | — | $10B | XXX | XXX | XXX |
Financial data powered by Morningstar, Inc.
DaVita Stock Performance
DaVita has current market cap of $10B, and enterprise value of $22B.
Market Cap Evolution
DaVita's stock price is $147.91.
| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $22B | $10B | 0.0% | XXX | XXX | XXX | $12.24 |
Benchmark Trading Valuation Multiples by Industry
Sign up to access valuation multiples like growth-adjusted P/E, Rule of 40, next 12-month EV/Revenue, EBITDA multiples by industry, consensus analyst estimates and many more.
Start Free TrialDaVita Valuation Multiples
DaVita trades at 1.6x EV/Revenue multiple, and 7.8x EV/EBITDA.
EV / Revenue (LTM)
DaVita Financial Valuation Multiples
As of April 19, 2026, DaVita has market cap of $10B and EV of $22B.
Equity research analysts estimate DaVita's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
DaVita has a P/E ratio of 11.5x.
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Market cap (current) | $10B | XXX | $10B | XXX | XXX | XXX |
| EV (current) | $22B | XXX | $22B | XXX | XXX | XXX |
| EV/Revenue | 1.6x | XXX | 1.6x | XXX | XXX | XXX |
| EV/EBITDA | 7.8x | XXX | 7.9x | XXX | XXX | XXX |
| EV/EBIT | 10.4x | XXX | 10.5x | XXX | XXX | XXX |
| EV/Gross Profit | 5.0x | XXX | 5.0x | XXX | XXX | XXX |
| P/E | 11.5x | XXX | 12.1x | XXX | XXX | XXX |
| EV/FCF | 21.5x | XXX | 16.8x | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Verified DaVita Valuation Multiples
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2027, based on consensus analyst estimates. Powered by FactSet and Morningstar.
DaVita Margins & Growth Rates
DaVita's revenue in the last 12 month grew by 3%.
DaVita's revenue per employee in the last FY averaged $0.2M, while opex per employee averaged $0.0M for the same period.
DaVita's rule of 40 is 23% (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).
DaVita's rule of X is 27% (created by Bessemer, rule of X is another metric to measure SaaS companies, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).
DaVita Operational Valuation Multiples
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Revenue Growth | 3% | XXX | 3% | XXX | XXX | XXX |
| EBITDA Margin | 21% | XXX | 21% | XXX | XXX | XXX |
| EBITDA Growth | 2% | XXX | 2% | XXX | XXX | XXX |
| Rule of 40 | — | XXX | 23% | XXX | XXX | XXX |
| Bessemer Rule of X | — | XXX | 27% | XXX | XXX | XXX |
| Revenue per Employee | — | XXX | $0.2M | XXX | XXX | XXX |
| Opex per Employee | — | XXX | $0.0M | XXX | XXX | XXX |
| G&A Expenses to Revenue | 12% | XXX | 12% | XXX | XXX | XXX |
| Opex to Revenue | — | XXX | 18% | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
DaVita Public Comps
See public comps and valuation multiples for other Hospitals & Clinics comps.
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| LTM | 2026E | 2027E | LTM | 2026E | 2027E | |
| DaVita | XXX | XXX | XXX | XXX | XXX | XXX |
| Bangkok Dusit Medical Services | XXX | XXX | XXX | XXX | XXX | XXX |
| Encompass Health | XXX | XXX | XXX | XXX | XXX | XXX |
| Max Healthcare Institute | XXX | XXX | XXX | XXX | XXX | XXX |
| Mayapada Hospital | XXX | XXX | XXX | XXX | XXX | XXX |
| Universal Health Services | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc.
DaVita M&A Activity
DaVita acquired XXX companies to date.
Last acquisition by DaVita was on XXXXXXXX, XXXXX. DaVita acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX).
Latest Acquisitions by DaVita
| Acquired Company | Valuation | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
Get Verified M&A Valuation Multiples
Sign up to see revenue and EBITDA valuation multiples for 150K+ M&A deals.
Start Free TrialDaVita Investment Activity
DaVita invested in XXX companies to date.
DaVita made its latest investment on XXXXXXXX, XXXXX. DaVita invested in XXXXXXXX for XXX (EV/Revenue multiple of XXX).
Latest Investments by DaVita
| Company | Valuation | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples
Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.
Start Free TrialAbout DaVita
| When was DaVita founded? | DaVita was founded in 1994. |
| Where is DaVita headquartered? | DaVita is headquartered in United States. |
| How many employees does DaVita have? | As of today, DaVita has over 78K employees. |
| Who is the CEO of DaVita? | DaVita's CEO is Javier J. Rodriguez. |
| Is DaVita publicly listed? | Yes, DaVita is a public company listed on NYSE. |
| What is the stock symbol of DaVita? | DaVita trades under DVA ticker. |
| When did DaVita go public? | DaVita went public in 1995. |
| Who are competitors of DaVita? | DaVita main competitors are Bangkok Dusit Medical Services, Encompass Health, Max Healthcare Institute, Mayapada Hospital. |
| What is the current market cap of DaVita? | DaVita's current market cap is $10B. |
| What is the current revenue of DaVita? | DaVita's last 12 months revenue is $14B. |
| What is the current revenue growth of DaVita? | DaVita revenue growth (NTM/LTM) is 3%. |
| What is the current EV/Revenue multiple of DaVita? | Current revenue multiple of DaVita is 1.6x. |
| Is DaVita profitable? | Yes, DaVita is EBITDA-positive (as of the last 12 months). |
| What is the current EBITDA of DaVita? | DaVita's last 12 months EBITDA is $3B. |
| What is DaVita's EBITDA margin? | DaVita's last 12 months EBITDA margin is 21%. |
| What is the current EV/EBITDA multiple of DaVita? | Current EBITDA multiple of DaVita is 7.8x. |
| What is the current FCF of DaVita? | DaVita's last 12 months FCF is $1B. |
| What is DaVita's FCF margin? | DaVita's last 12 months FCF margin is 7%. |
| What is the current EV/FCF multiple of DaVita? | Current FCF multiple of DaVita is 21.5x. |
Start Your
Free Trial Today
Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.